ID: ALA5274427

Max Phase: Preclinical

Molecular Formula: C6H11NO4

Molecular Weight: 161.16

Associated Items:

Representations

Canonical SMILES:  CN(O)C(=O)CCCC(=O)O

Standard InChI:  InChI=1S/C6H11NO4/c1-7(11)5(8)3-2-4-6(9)10/h11H,2-4H2,1H3,(H,9,10)

Standard InChI Key:  JFEAEEFTHWVOQX-UHFFFAOYSA-N

Associated Targets(non-human)

1-deoxyxylulose-5-phosphate reductoisomerase 147 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 161.16Molecular Weight (Monoisotopic): 161.0688AlogP: 0.09#Rotatable Bonds: 4
Polar Surface Area: 77.84Molecular Species: ACIDHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.26CX Basic pKa: CX LogP: -0.54CX LogD: -3.57
Aromatic Rings: 0Heavy Atoms: 11QED Weighted: 0.45Np Likeness Score: -0.01

References

1. Kesharwani S, Sundriyal S..  (2021)  Non-hydroxamate inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXR): A critical review and future perspective.,  213  [PMID:33303239] [10.1016/j.ejmech.2020.113055]

Source